Literature DB >> 18079636

[A patient with recurrent sigmoid colon cancer in whom pleural effusion and ascites resolved after FOLFOX 4 therapy].

Masatoshi Akamatsu1, Yousuke Tsuji, Wachiko Nakata, Tomoya Ohmae, Ken Ohata, Saburo Matsubara, Tetsuo Katamoto.   

Abstract

We performed combination therapy with oxaliplatin/l-LV/5-FU (FOLFOX 4) in a patient with recurrent colorectal cancer (a 58-year-old man) who had pleural effusion and ascites. This resulted in disappearance of the pleural effusion and ascites, as well as negative tumor markers. Surgery was performed for sigmoid colon cancer on September 29, 2004. In February 2006, abdominal swelling was observed, and CEA increased to 15 ng/mL with multiple intraabdominal tumor nodules. The patient was diagnosed as having peritonitis carcinomatosis associated with recurrent sigmoid colon cancer, and was treated with FOLFOX 4. CEA was 134.9 ng/mL before treatment, but became negative after six courses, while his pleural effusion and ascites disappeared after 10 courses of treatment. This treatment also appeared to be useful for recurrent colorectal cancer with peritoneal dissemination.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18079636

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  1 in total

1.  Refractory left pleural effusion in an older patient: Atypical presentation of colorectal carcinoma.

Authors:  Yujie Yuan; Jinning Ye; Chuangqi Chen; Wu Song; Jianbo Xu; Jianhui Chen; Yaping Xing; Yulong He
Journal:  Oncol Lett       Date:  2015-01-05       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.